AUS
NZ
UK
CA
USA
IND
Healthcare
Pediatrix (NYSE:MD) Slips on EPS Miss; NYSE Composite Reaction
February 20, 2026 10:08 AM PST| By Anmol KhazanchiPediatrix Medical Group posts quarterly earnings below expectations with stable liquidity and ongoing clinical expansion as part of the NYSE Composite healthcare segment.
Is Xenon Pharmaceuticals (NASDAQ:XENE) Rising In The Nasdaq Index
February 20, 2026 12:00 AM PST| By Team Kalkine MediaXenon Pharmaceuticals Inc. (NASDAQ:XENE) draws attention amid institutional activity, valuation benchmarks, and broader nasdaq index market momentum.
Alvotech (NASDAQ:ALVO) Faces Valuation Reset As Nasdaq Futures Turn
February 20, 2026 12:00 AM PST| By Anmol KhazanchiAlvotech (NASDAQ:ALVO) faces rating adjustment amid broader biotech momentum shaped by Nasdaq Futures and exchange-wide liquidity trends.
Is AtriCure (NASDAQ:ATRC) Facing New Pressure In The Nasdaq Index?
February 20, 2026 12:00 AM PST| By Anmol KhazanchiAtriCure (NASDAQ:ATRC) faces brokerage downgrade while Nasdaq Index activity influences medical device sector valuation and trading tone.
Is Nuvalent (NASDAQ:NUVL) Entering a Key Phase With Nasdaq Index Fund
February 20, 2026 12:00 AM PST| By Anmol KhazanchiNuvalent (NASDAQ:NUVL) draws attention as brokerage consensus and institutional activity align with Nasdaq Index Fund biotechnology momentum.
How Medtronic (NYSE:MDT) Reacts To Market Sentiment In S&P 500 Futures
February 20, 2026 12:00 AM PST| By Anmol KhazanchiMedtronic (NYSE:MDT) excels in medical technology, with a diverse portfolio and innovation driving growth. Its performance impacts the S&P 500 futures and shapes healthcare's future.
AbbVie (NYSE:ABBV) At Midday As Traders Watch Nyse Composite Closely
February 19, 2026 04:06 PM PST| By Anmol KhazanchiAbbVie operates in the health care sector, within the biopharmaceutical space where research, regulatory progress, manufacturing reliability, and commercial execution can all influence daily trading.
Artivion Inc (NYSE:AORT) Devices Strategy And Nyse Composite Index Sector Rotation
February 19, 2026 01:32 PM PST| By Anmol KhazanchiArtivion operates in the cardiovascular medical device sector, supplying technologies used in surgical and clinical settings that focus on the heart and major blood vessels. This area of healthcare is shaped by product quality.
Johnson and Johnson Surges in s&p 500 Spotlight
February 19, 2026 01:32 PM PST| By Anmol KhazanchiJohnson and Johnson gains attention in the s&p 500 after hitting a fresh peak, announcing manufacturing expansion, regulatory progress, and updated quarterly earnings.
Johnson Johnson (NYSE:JNJ) Dates Near Dow Jones Industrials Average Key Moves Today
February 19, 2026 01:11 PM PST| By Anmol KhazanchiJohnson & Johnson operates within the healthcare sector, spanning medicines and a range of health-related products and services. Within this sector, established issuers often maintain regular.
GSK (NYSE:GSK) Sees Options Surge in NYSE Composite
February 19, 2026 12:49 PM PST| By Anmol KhazanchiGSK draws attention on the NYSE Composite following heightened derivatives activity, shareholder disclosures, and ongoing developments in global pharmaceutical operations.
Neurocrine (NASDAQ:NBIX) Downgrade Shifts Focus Across Nasdaq Index
February 19, 2026 12:00 AM PST| By Anmol KhazanchiNeurocrine (NASDAQ:NBIX) enters renewed Nasdaq Index focus after a brokerage downgrade, as investors reassess valuation, margin durability, and institutional positioning.
Xenon (NASDAQ:XENE) Short-Term Positioning Shifts In Nasdaq Futures
February 19, 2026 12:00 AM PST| By Anmol KhazanchiXenon (NASDAQ:XENE) enters Nasdaq Futures focus as heavy put option activity and steady institutional rotation shape short-term sentiment in biotech trading.
Rhythm (NASDAQ:RYTM) Capital Discipline Gains Nasdaq 100 Index Focus
February 19, 2026 12:00 AM PST| By Anmol KhazanchiRhythm (NASDAQ:RYTM) re-enters Nasdaq 100 Index discussions after a coverage update, as institutional activity and pipeline focus shape biotech positioning.
How Alnylam (NASDAQ:ALNY) Is Reframing Nasdaq Index Fund Allocation Trends
February 19, 2026 12:00 AM PST| By Anmol KhazanchiAlnylam Pharmaceuticals (NASDAQ:ALNY) draws Nasdaq index fund focus following a rating upgrade and solid quarterly performance despite mixed consensus results.
TC Energy (NYSE:TRP) Brokerage Rating Shift Explains Why Ratings Changes Move Markets
February 18, 2026 04:29 PM PST| By Anmol KhazanchiTC Energy Corp (NYSE:TRP) with pipeline corridors and related facilities that support the steady flow of natural gas and other energy products between production regions, storage hubs, and demand centres.
Glaukos (NYSE:GKOS) Jumps After Qtrly Revenue Beat
February 18, 2026 02:18 PM PST| By Anmol KhazanchiGlaukos Corporation performance within NYSE Composite reflects recent earnings results, evolving ophthalmic technologies, and ongoing commercial expansion across glaucoma and corneal care segments.
Bristol Myers Squibb (NYSE:BMY) Delivers Stability While S&P 500 Stays Volatile
February 18, 2026 01:17 PM PST| By Anmol KhazanchiThe healthcare sector includes global biopharma groups that develop, manufacture, and distribute prescription therapies across areas such as oncology, immunology, and cardiovascular care.
Is Prenetics Global (NASDAQ:PRE) Surprising Markets In Nasdaq Today Session
February 18, 2026 12:00 AM PST| By Anmol KhazanchiPrenetics Global (NASDAQ:PRE) drew attention in Nasdaq Today trading after surpassing projections, signaling restructuring progress and continued volatility in the diagnostics sector.
Fortrea (NASDAQ:FTRE) Trading Momentum Aligns With Nasdaq Futures Trends
February 18, 2026 12:00 AM PST| By Anmol KhazanchiFortrea (NASDAQ:FTRE) remains active in Nasdaq futures discussions as coverage consensus, balanced liquidity, and steady institutional engagement shape its CDMO sector positioning.
